Prevalence of atypical antipsychotic use in psychiatric outpatients: comparison of women of childbearing age with men

Archives of Women's Mental Health

Volumn 17, Issue 6, 2014, Pages 583-586

  Çamsarı, Ulas ^a   Viguera, Adele C ^b,c,d   Ralston, Laurel ^d   Baldessarini, Ross J ^b,e   Cohen, Lee S ^b,c  

^a Mayo Clinic College of Medicine   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e MCLEAN HOSPITAL   (United States)

Author keywords

Anxiety disorders; Atypical antipsychotics; Childbearing age women; Mood disorders; Second generation antipsychotics; Sex differences

Indexed keywords

ARIPIPRAZOLE; ASENAPINE; ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; ILOPERIDONE; OLANZAPINE; PALIPERIDONE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE; ANTIDEPRESSANT AGENT; NEUROLEPTIC AGENT;

ADULT; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; COMPARATIVE STUDY; DRUG USE; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL HOSPITAL; MOOD DISORDER; OFF LABEL DRUG USE; OUTPATIENT DEPARTMENT; PRESCRIPTION; PREVALENCE; PSYCHOSIS; SCHIZOPHRENIA; SEX DIFFERENCE; SUBSTANCE ABUSE; TERTIARY CARE CENTER; DEPRESSIVE DISORDER, MAJOR; OUTPATIENT; PSYCHOTIC DISORDERS; SEX RATIO; TREATMENT OUTCOME;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIPSYCHOTIC AGENTS; DEPRESSIVE DISORDER, MAJOR; ELECTRONIC HEALTH RECORDS; FEMALE; HOSPITALS, PSYCHIATRIC; HUMANS; MALE; OFF-LABEL USE; OUTPATIENTS; PREVALENCE; PSYCHOTIC DISORDERS; SEX DISTRIBUTION; TREATMENT OUTCOME;

EID: 84916938823     PISSN: 14341816     EISSN: 14351102     Source Type: Journal    
DOI: 10.1007/s00737-014-0465-0     Document Type: Article

References (18)

1. Abel KM (2013) Fetal antipsychotic exposure in a changing landscape: seeing the future. Br J Psychiatry 202(5):321–323
2. Ajmal A, Joffe H, Nachtigall LB (2014) Psychotropic-induced hyperprolactinemia: a clinical review. Psychosomatics 55(1):29–36
3. Alexander GC, Gallagher SA, Mascola A, Moloney RM, Stafford RS (2011) Increasing off-label use of antipsychotic medications in the United States, 1995–2008. Pharmacoepidemiol Drug Saf 20(2):177–184
4. Baldessarini RJ (2013) Chemotherapy in psychiatry, 3rd edn. Springer Press, New York
5. Cunnington M, Messenheimer J (2008) Pregnancy registries: strengths, weaknesses, and bias: interpretation of pregnancy data. Int Rev Neurobiol 83:283–304
6. Habermann F, Fritzsche J, Fuhlbrück F, Wacker E, Allignol A, Weber-Schoendorfer C, Meister R, Schaefer C (2013) Atypical antipsychotic drugs and pregnancy outcome: prospective, cohort study. J Clin Psychopharmacol 33(4):453–462
7. Johnson KC, LaPrairie JL, Brennan P, Stowe ZN, Newport DJ (2012) Prenatal antipsychotic exposure and neuromotor performance during infancy. Arch Gen Psychiatry 69(8):787–794
8. Katzan I, Speck M, Dopler C, Urchek J, Bielawski K, Dunphy C, Jehi L, Bae C, Parchman A (2011) The knowledge program: an innovative, comprehensive electronic data capture system and warehouse. AMIA Annu Symp Proc 2011:683–692
9. Kennedy DL, Uhl K, Kweder SL (2004) Pregnancy exposure registries. Drug Saf 27(4):215–228
10. McKenna K, Koren G, Tetelbaum M, Wilton L, Shakir S, Diav-Citrin O, Levinson A, Zipursky RB, Einarson A (2005) Pregnancy outcome of women using atypical antipsychotic drugs: prospective comparative study. J Clin Psychiatry 66(4):444–449
11. Nasrallah HA (2006) Metabolic findings from the CATIE trial and their relation to tolerability. CNS Spectr 11(7 Suppl 7):32–39
12. Reis M, Källén B (2008) Maternal use of antipsychotics in early pregnancy and delivery outcome. J Clin Psychopharmacol 28(3):279–288
13. Sadowski A, Todorow M, Yazdani-Brojeni P, Koren G, Nulman I (2013) Pregnancy outcomes following maternal exposure to second-generation antipsychotics given with other psychotropic drugs: cohort study. BMJ Open 3(7):e003062
14. Thomas SH, Yates LM (2012) Prescribing without evidence—pregnancy. Br J Clin Pharmacol 74(4):691–697
15. Toh S, Li Q, Cheetham TC, Cooper WO, Davis RL, Dublin S, Hammad TA, Li DK, Pawloski PA, Pinheiro SP, Raebel MA, Scott PE, Smith DH, Bobo WV, Lawrence JM, Dashevsky I, Haffenreffer K, Avalos LA, Andrade SE (2013) Prevalence and trends in the use of antipsychotic medications during pregnancy in the US, 2001–2007: population-based study of 585,615 deliveries. Arch Womens Ment Health 16(2):149–157
16. Tomson T, Battino D, Craig J, Hernandez-Diaz S, Holmes LB, Lindhout D, Morrow J, French J, ILAE Commission on Therapeutic Strategies (2010) Pregnancy registries: differences, similarities, and possible harmonization. Epilepsia 5(5):909–915
17. Vajda FJ (2010) The Australian pregnancy register of anti-epileptic drugs: 10 years of progress. J Clin Neurosci 17(12):1485–1488
18. Wichman CL (2009) Atypical antipsychotic use in pregnancy: retrospective review. Arch Womens Ment Health 12(1):53–57